Decursin-Loaded Poly-L-Lactic Acid Microspheres Surface-Functionalized with Chemokine CCL17 Alleviate Allergic Rhinitis by Modulating Regulatory T Cells
Nano · 14.08.2026
DOI: 10.1142/s1793292026501523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano, online erschienen am 14.08.2026. Verfasst von Xiangming Huang und 6 weiteren Autor:innen. Gefördert von: Natural Science Foundation of Guangxi.
Abstract (Originalsprache)
Background
Decursin (Dec) has been identified as a potential component for treating allergic rhinitis (AR), but poor water solubility limits its application. This investigation was intended to develop a novel drug delivery system to optimize the therapeutic effects of Dec.
Methods
Dec@PLLA-CCL17 was prepared and its drug delivery performance was assessed. Tregs were treated with PLLA, PLLA-CCL17, Dec, Dec@PLLA, or Dec@PLLA-CCL17. Cell viability was detected by CCK-8 assay, and the association between microspheres and Tregs was visualized by laser confocal microscopy. IL-4, IL-10 and TGF-[Formula: see text] levels in Tregs were measured using ELISA. Ovalbumin-induced AR mice were administered with Dec@PLLA or Dec@PLLA-CCL17, and nasal scoring was conducted. Pathological changes of the nasal mucosa were evaluated through hematoxylin and eosin (HE) staining. Treg numbers were assessed using flow cytometry, and histamine, IL-4, IL-10 and TGF-[Formula: see text] levels were detected using ELISA. Apoptosis was assessed by TUNEL staining and Western blot.
Results
Dec@PLLA-CCL17 showed favorable drug delivery properties. PLLA and PLLA-CCL17 had no effect on the viability of Tregs. Furthermore, Tregs exhibited a stronger association with Dec@PLLA-CCL17 than with Dec@PLLA. Dec, Dec@PLLA and Dec@PLLA-CCL17 all remarkably increased cell viability and IL-10 and TGF-[Formula: see text] levels, while reducing IL-4 levels in Tregs, with Dec@PLLA-CCL17 having the strongest effect. In AR mice, both Dec@PLLA and Dec@PLLA-CCL17 notably reduced nasal symptom scores, alleviated nasal mucosal damage, increased Treg numbers, elevated IL-10 and TGF-[Formula: see text] levels, decreased histamine and IL-4 levels, and reduced apoptosis, with Dec@PLLA-CCL17 showing superior effects.
Conclusion
Dec@PLLA-CCL17 alleviates AR by enhancing the proliferation and immunosuppressive function of Tregs.
Förderung
- Natural Science Foundation of Guangxi
Zitieren
APA
Huang, X., Li, Y., Chen, X., Huang, Z., Liao, W., Zheng, Q., & Gao, Y. (2026). Decursin-Loaded Poly-L-Lactic Acid Microspheres Surface-Functionalized with Chemokine CCL17 Alleviate Allergic Rhinitis by Modulating Regulatory T Cells. Nano. https://doi.org/10.1142/s1793292026501523
Vancouver
Huang X, Li Y, Chen X, Huang Z, Liao W, Zheng Q, et al. Decursin-Loaded Poly-L-Lactic Acid Microspheres Surface-Functionalized with Chemokine CCL17 Alleviate Allergic Rhinitis by Modulating Regulatory T Cells. Nano. 2026. doi:10.1142/s1793292026501523
BibTeX
@article{Huang2026,
author = {Huang, Xiangming and Li, Yi and Chen, Xiao and Huang, Zhuoyan and Liao, Wei and Zheng, Qinyuan and Gao, Yang},
title = {Decursin-Loaded Poly-L-Lactic Acid Microspheres Surface-Functionalized with Chemokine CCL17 Alleviate Allergic Rhinitis by Modulating Regulatory T Cells},
journal = {Nano},
year = {2026},
doi = {10.1142/s1793292026501523}
}
EUVIMED